Reps. Finstad and Crenshaw, Sen. Paul Introduce Resolution to Repeal Harmful FDA Rule Limiting Access to Laboratory Developed Tests
May 17, 2024
May 17, 2024
WASHINGTON, May 17 -- Rep. Brad Finstad, R-Minnesota, issued the following news release:
Congressmen Brad Finstad (MN-01) and Dan Crenshaw (TX-02) introduced a resolution under the Congressional Review Act (CRA) to repeal Medical Devices: Laboratory Developed Tests (LDTs), a rule that was recently finalized by the Food and Drug Administration (FDA). U.S. Senator Rand Paul (R-KY) introduced the resolution in the U.S. Senate. The final rule, published May 6th, seeks to impose burdenso . . .
Congressmen Brad Finstad (MN-01) and Dan Crenshaw (TX-02) introduced a resolution under the Congressional Review Act (CRA) to repeal Medical Devices: Laboratory Developed Tests (LDTs), a rule that was recently finalized by the Food and Drug Administration (FDA). U.S. Senator Rand Paul (R-KY) introduced the resolution in the U.S. Senate. The final rule, published May 6th, seeks to impose burdenso . . .